Time for recognition of lay counsellors
Accessed November 2017
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Global Plan to end TB 2016-2020
Informe sobre poblaciones clave
Moving from accelerated burden reduction to malaria elimination in Zambia
WHO clinical guidelines.
For the first time, WHO has published guidelines to help (primarily) front-line healthcare providers give high-quality, compassionate, and respectful care to children and adolescents (up to age 18) who have or may have experienced sexual abuse, including sexual assault or r...ape.
more
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...cidence, prevalence and mortality, albeit with variations across countries. By the end of 2015, the Region as a whole met the key Millennium Development Goal (MDG) target of halting and beginning to reverse TB incidence. However only 35 of the 47 Member States met the MDG target.
more
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
3rd Edition – July 2017
www.msfaccess.org
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more